Disclaimer: That Intended For Medical Professionals Only
AjantaMed Dialogue
Log In/Register
AjantaMed Dialogue
Stay Informed, Stay Ahead
Latest News :
New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management • New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management •
sticky-medbot
Dry Eye Disease: Clinical Thresholds for Initiating Lifitegrast Across Subtypes

Dry Eye Disease: Clinical Thresholds for Initiating Lifitegrast Across Subtypes

Dry eye disease encompasses multiple subtypes with varying inflammatory drivers, making timely initiation of anti-inflammatory therapy critical. This video explores the clinical threshold for initiating Lifitegrast (Lifanta) across common dry eye subtypes, including aqueous-deficient dry eye, meibomian gland dysfunction (MGD), and post-menopausal dry eye.

By : Dr. Eric Donnenfled

Recommended Videos

Dr Elankumaran Pasupathi – Case Study 5
Ophthalmology

Dr Elankumaran Pasupathi – Case Study 5

Dr Harshvardhan Ghorpade – Case 4
Ophthalmology

Dr Harshvardhan Ghorpade – Case 4

Dr Bhaskar Srinivasan – Case 3
Ophthalmology

Dr Bhaskar Srinivasan – Case 3

Dr Madhu Uddaraju – Case 2
Ophthalmology

Dr Madhu Uddaraju – Case 2

Subscribe to our newsletter

Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.